Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment
On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…
On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…
On Feb. 20, 2023, results from a randomized clinical trial of Ivermectin in a higher-hose and longer duration…
On Mar. 31, 2022, researchers in Brazil reported that a study of COVID-19 patients at 12 clinics that…
On Feb. 4, 2021, Merck affirmed its position regarding use of ivermectin during the COVID-19 pandemic, and do…
On Oct. 5, 2015, Tu Youyou was awarded a half share of the Nobel Prize in Physiology or…
In 1981, Merck began commercialize ivermectin as a broad-spectrum veterinary anti-parasitic drug that was originally developed to treat…
In 1973, Satoshi Ōmura discovered the extraordinary microorganism that produces the avermectins (from which ivermectin is derived) that…